{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:10:11Z","timestamp":1790536211007,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T00:00:00Z","timestamp":1553817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1127198"],"award-info":[{"award-number":["1127198"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1075666"],"award-info":[{"award-number":["1075666"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003747","name":"Department of Health, State Government of Victoria","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003747","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Holmes Grant Charitable Trust"},{"name":"Walter and Eliza Hall Institute Innovation Grant"},{"name":"Bloody Long Way"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2019,4,15]]},"DOI":"10.1007\/s10875-019-00602-x","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T09:02:29Z","timestamp":1553850149000},"page":"324-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Fatal Enteroviral Encephalitis in a Patient with Common Variable Immunodeficiency Harbouring a Novel Mutation in NFKB2"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9020-1487","authenticated-orcid":false,"given":"Charlotte A.","family":"Slade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Scerri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Binh","family":"Giang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Megaloudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Strathmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica C.","family":"Tempany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"D\u2019Arcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Bahlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"Hodgkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo A.","family":"Douglass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,29]]},"reference":[{"issue":"2","key":"602_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1084\/jem.187.2.185","volume":"187","author":"JH Caamano","year":"1998","unstructured":"Caamano JH, et al. Nuclear factor (NF)-kappa B2 (p100\/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med. 1998;187(2):185\u201396.","journal-title":"J Exp Med"},{"issue":"5","key":"602_CR2","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ajhg.2013.09.009","volume":"93","author":"K Chen","year":"2013","unstructured":"Chen K, Coonrod EM, Kum\u00e1novics A, Franks ZF, Durtschi JD, Margraf RL, et al. Germline mutations in NFKB2 implicate the noncanonical NF-kappaB pathway in the pathogenesis of common variable immunodeficiency. Am J Hum Genet. 2013;93(5):812\u201324.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"602_CR3","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1007\/s10875-014-0095-3","volume":"34","author":"AW Lindsley","year":"2014","unstructured":"Lindsley AW, Qian Y, Valencia CA, Shah K, Zhang K, Assa\u2019ad A. Combined immune deficiency in a patient with a novel NFKB2 mutation. J Clin Immunol. 2014;34(8):910\u20135.","journal-title":"J Clin Immunol"},{"issue":"19","key":"602_CR4","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1182\/blood-2014-06-578542","volume":"124","author":"CE Lee","year":"2014","unstructured":"Lee CE, Fulcher DA, Whittle B, Chand R, Fewings N, Field M, et al. Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100. Blood. 2014;124(19):2964\u201372.","journal-title":"Blood"},{"issue":"6","key":"602_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s10875-014-0064-x","volume":"34","author":"Y Liu","year":"2014","unstructured":"Liu Y, Hanson S, Gurugama P, Jones A, Clark B, Ibrahim MAA. Novel NFKB2 mutation in early-onset CVID. J Clin Immunol. 2014;34(6):686\u201390.","journal-title":"J Clin Immunol"},{"key":"602_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12881-014-0139-9","volume":"15","author":"T Brue","year":"2014","unstructured":"Brue T, Quentien MH, Khetchoumian K, Bensa M, Capo-Chichi JM, Delemer B, et al. Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies. BMC Med Genet. 2014;15:139.","journal-title":"BMC Med Genet"},{"issue":"40","key":"602_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005081","volume":"95","author":"C Shi","year":"2016","unstructured":"Shi C, Wang F, Tong A, Zhang XQ, Song HM, Liu ZY, et al. NFKB2 mutation in common variable immunodeficiency and isolated adrenocorticotropic hormone deficiency. Medicine. 2016;95(40):e5081.","journal-title":"Medicine"},{"issue":"6","key":"602_CR8","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.jaci.2014.11.038","volume":"135","author":"V Lougaris","year":"2015","unstructured":"Lougaris V, Tabellini G, Vitali M, Baronio M, Patrizi O, Tampella G, et al. Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease. J Allergy Clin Immunol. 2015;135(6):1641\u20133.","journal-title":"J Allergy Clin Immunol"},{"issue":"13","key":"602_CR9","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1182\/blood-2017-05-782177","volume":"130","author":"HS Kuehn","year":"2017","unstructured":"Kuehn HS, Niemela JE, Sreedhara K, Stoddard JL, Grossman J, Wysocki CA, et al. Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype. Blood. 2017;130(13):1553\u201364.","journal-title":"Blood"},{"issue":"11","key":"602_CR10","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1172\/JCI28326","volume":"116","author":"M Zhu","year":"2006","unstructured":"Zhu M, Chin RK, Christiansen PA, Lo JC, Liu X, Ware C, et al. NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway. J Clin Invest. 2006;116(11):2964\u201371.","journal-title":"J Clin Invest"},{"issue":"5","key":"602_CR11","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.4049\/jimmunol.0801752","volume":"182","author":"AL Fletcher","year":"2009","unstructured":"Fletcher AL, Seach N, Reiseger JJ, Lowen TE, Hammett MV, Scott HS, et al. Reduced thymic Aire expression and abnormal NF-kappa B2 signaling in a model of systemic autoimmunity. J Immunol. 2009;182(5):2690\u20139.","journal-title":"J Immunol"},{"issue":"10","key":"602_CR12","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/hmg\/7.10.1547","volume":"7","author":"P Bjorses","year":"1998","unstructured":"Bjorses P, et al. Gene defect behind APECED: a new clue to autoimmunity. Hum Mol Genet. 1998;7(10):1547\u201353.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"602_CR13","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jaci.2017.11.014","volume":"141","author":"KA Ramakrishnan","year":"2018","unstructured":"Ramakrishnan KA, Rae W, Barcenas-Morales G, Gao Y, Pengelly RJ, Patel SV, et al. Anticytokine autoantibodies in a patient with a heterozygous NFKB2 mutation. J Allergy Clin Immunol. 2018;141(4):1479\u20131482 e6.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"602_CR14","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1038\/cti.2017.41","volume":"6","author":"R Ameratunga","year":"2017","unstructured":"Ameratunga R, Koopmans W, Woon ST, Leung E, Lehnert K, Slade CA, et al. Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus. Clin Transl Immunol. 2017;6(10):e159.","journal-title":"Clin Transl Immunol"},{"issue":"3","key":"602_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajhg.2015.07.008","volume":"97","author":"M Fliegauf","year":"2015","unstructured":"Fliegauf M, L. Bryant V, Frede N, Slade C, Woon ST, Lehnert K, et al. Haploinsufficiency of the NF-kappaB1 subunit p50 in common variable immunodeficiency. Am J Hum Genet. 2015;97(3):389\u2013403.","journal-title":"Am J Hum Genet"},{"key":"602_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.coi.2014.05.004","volume":"30","author":"ME Conley","year":"2014","unstructured":"Conley ME, Casanova JL. Discovery of single-gene inborn errors of immunity by next generation sequencing. Curr Opin Immunol. 2014;30:17\u201323.","journal-title":"Curr Opin Immunol"},{"key":"602_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fimmu.2016.00220","volume":"7","author":"P Maffucci","year":"2016","unstructured":"Maffucci P, et al. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front Immunol. 2016;7:220.","journal-title":"Front Immunol"},{"issue":"3","key":"602_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jaci.2016.10.054","volume":"140","author":"M Kaustio","year":"2017","unstructured":"Kaustio M, Haapaniemi E, G\u00f6\u00f6s H, Hautala T, Park G, Syrj\u00e4nen J, et al. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. J Allergy Clin Immunol. 2017;140(3):782\u201396.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"602_CR19","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1111\/1346-8138.14524","volume":"46","author":"M Nagai","year":"2019","unstructured":"Nagai M, Imai Y, Yamanishi K. Psoriasiform dermatitis associated with common variable immunodeficiency 10 due to an Arg853* mutation in the NFKB2 gene. J Dermatol. 2019;46(1):e24\u20136.","journal-title":"J Dermatol"},{"issue":"1","key":"602_CR20","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","volume":"134","author":"B Gathmann","year":"2014","unstructured":"Gathmann B, Mahlaoui N, CEREDIH, G\u00e9rard L, Oksenhendler E, Warnatz K, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116\u201326.","journal-title":"J Allergy Clin Immunol"},{"key":"602_CR21","doi-asserted-by":"crossref","unstructured":"Schwab C, et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4\u2013insufficient subjects. J Allergy Clin Immunol. 2018;142(6):1932\u201346.","DOI":"10.1016\/j.jaci.2018.02.055"},{"issue":"2","key":"602_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4161\/hv.27087","volume":"10","author":"Q Mao","year":"2014","unstructured":"Mao Q, Wang Y, Yao X, Bian L, Wu X, Xu M, et al. Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother. 2014;10(2):360\u20137.","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"602_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/BF00918150","volume":"12","author":"SA Misbah","year":"1992","unstructured":"Misbah SA, Spickett GP, Ryba PCJ, Hockaday JM, Kroll JS, Sherwood C, et al. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J Clin Immunol. 1992;12(4):266\u201370.","journal-title":"J Clin Immunol"},{"issue":"2","key":"602_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/clinids\/9.2.334","volume":"9","author":"RE McKinney Jr","year":"1987","unstructured":"McKinney RE Jr, Katz SL, Wilfert CM. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis. 1987;9(2):334\u201356.","journal-title":"Rev Infect Dis"},{"issue":"26","key":"602_CR25","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1056\/NEJM197706302962601","volume":"296","author":"CM Wilfert","year":"1977","unstructured":"Wilfert CM, Buckley RH, Mohanakumar T, Griffith JF, Katz SL, Whisnant JK, et al. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med. 1977;296(26):1485\u20139.","journal-title":"N Engl J Med"},{"issue":"9","key":"602_CR26","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.3201\/eid2109.150104","volume":"21","author":"C Dendle","year":"2015","unstructured":"Dendle C, Gilbertson M, Korman TM, Golder V, Morand E, Opat S. Disseminated enteroviral infection associated with obinutuzumab. Emerg Infect Dis. 2015;21(9):1661\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"602_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.anai.2015.05.007","volume":"115","author":"T Palacios","year":"2015","unstructured":"Palacios T, Bartelt L, Scheld W, Lopes MB, Kelting SM, Holland S, et al. Fatal Coxsackie meningoencephalitis in a patient with B-cell lymphopenia and hypogammaglobulinemia following rituximab therapy. Ann Allergy Asthma Immunol. 2015;115(2):148\u201350.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"602_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s10875-015-0164-2","volume":"35","author":"A NaserEddin","year":"2015","unstructured":"NaserEddin A, Shamriz O, Keller B, Alzyoud RM, Unger S, Fisch P, et al. Enteroviral infection in a patient with BLNK adaptor protein deficiency. J Clin Immunol. 2015;35(4):356\u201360.","journal-title":"J Clin Immunol"},{"issue":"4","key":"602_CR29","first-page":"538","volume":"22","author":"S Mantri","year":"2016","unstructured":"Mantri S, Shah BB. Enterovirus causes rapidly progressive dementia in a 28-year-old immunosuppressed woman. J Neuro-Oncol. 2016;22(4):538\u201340.","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"602_CR30","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/CMR.13.4.602","volume":"13","author":"MA Keller","year":"2000","unstructured":"Keller MA, Stiehm ER. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev. 2000;13(4):602\u201314.","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"602_CR31","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa1304923","volume":"370","author":"F Zhu","year":"2014","unstructured":"Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370(9):818\u201328.","journal-title":"N Engl J Med"},{"issue":"6","key":"602_CR32","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jaip.2015.12.015","volume":"4","author":"D Bearden","year":"2016","unstructured":"Bearden D, Collett M, Quan PL, Costa-Carvalho BT, Sullivan KE. Enteroviruses in X-linked agammaglobulinemia: update on epidemiology and therapy. J Allergy Clin Immunol Pract. 2016;4(6):1059\u201365.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"602_CR33","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s00705-011-1222-6","volume":"157","author":"G Zhang","year":"2012","unstructured":"Zhang G, Zhou F, Gu B, Ding C, Feng D, Xie F, et al. In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Arch Virol. 2012;157(4):669\u201379.","journal-title":"Arch Virol"},{"key":"602_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pediatrneurol.2016.06.014","volume":"64","author":"J Gofshteyn","year":"2016","unstructured":"Gofshteyn J, Cardenas AM, Bearden D. Treatment of chronic enterovirus encephalitis with fluoxetine in a patient with X-linked agammaglobulinemia. Pediatr Neurol. 2016;64:94\u20138.","journal-title":"Pediatr Neurol"},{"issue":"4","key":"602_CR35","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.celrep.2014.12.054","volume":"10","author":"JR Strating","year":"2015","unstructured":"Strating JR, et al. Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. Cell Rep. 2015;10(4):600\u201315.","journal-title":"Cell Rep"},{"issue":"8","key":"602_CR36","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10875-016-0336-8","volume":"36","author":"JT Nguyen","year":"2016","unstructured":"Nguyen JT, et al. Neurologic complications of common variable immunodeficiency. J Clin Immunol. 2016;36(8):793\u2013800.","journal-title":"J Clin Immunol"},{"issue":"7","key":"602_CR37","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1469-8749.2008.03217.x","volume":"51","author":"CI Akman","year":"2009","unstructured":"Akman CI, et al. Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency. Dev Med Child Neurol. 2009;51(7):563\u20137.","journal-title":"Dev Med Child Neurol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00602-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-019-00602-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00602-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T21:02:04Z","timestamp":1659042124000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-019-00602-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,29]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,4,15]]}},"alternative-id":["602"],"URL":"https:\/\/doi.org\/10.1007\/s10875-019-00602-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,29]]},"assertion":[{"value":"6 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patients and their healthy relatives were recruited from the Department of Clinical Immunology and Allergy, Royal Melbourne Hospital, Victoria, Australia. Informed consent was obtained from all individual participants included in the study for genomic analysis and functional immunologic studies prior to inclusion in the study. All procedures performed in studies involving human participants were in accordance with the ethical standards of Human Research Ethics Committees at Melbourne Health and The Walter and Eliza Hall Institute for Medical Research (Approved projects 2009.162, 10\/02) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}